The increased TGF-β1 levels identified in patients with moderate-severe OSA indicate that this disorder has an incremental effect on the expression and release of active TGF-β1 even in patients who have already developed a melanoma. The gene discussed is TGFB1; the disease is obstructive sleep apnea syndrome.